Akèy › Karsinom Duktal In Situ (DCIS)
Etid klinik pou Karsinom Duktal In Situ (DCIS) ap rekrite nan Etazini
30 etid pou Karsinom Duktal In Situ (DCIS) ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX5 etid
- New York City, NY5 etid
- Columbus, OH4 etid
- Chicago, IL4 etid
- Tampa, FL3 etid
- Philadelphia, PA3 etid
- Kansas City, KS3 etid
Pa eta
- Florid7 etid
- Illinois5 etid
- Kalifòni7 etid
- Kansas3 etid
- Michigan4 etid
- New York6 etid
- Ohio5 etid
- Oregon3 etid
- Pennsylvania4 etid
- Texas5 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Sep 28, 2026 · NCT06075953CAN1012 in Pre-Malignant DCIS and LCIS
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07408856Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy
Ap rekrite
Laj 40 ak plis · Fanm · Mizajou Sep 23, 2026 · NCT07711847Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Ap rekriteVolontè an sante akeyi
Laj 30 a 74 · Fanm · Mizajou Sep 21, 2026 · NCT02620852Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Ap rekriteFaz 2
Laj 45 ak plis · Fanm · Mizajou Sep 21, 2026 · NCT04084730Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06903468Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)
Ap rekriteFaz 2
Laj 50 ak plis · Fanm · Mizajou Sep 3, 2026 · NCT06902311Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Aug 18, 2026 · NCT06218303Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Ap rekriteFaz 2Volontè an sante akeyi
Laj 45 a 74 · Fanm · Mizajou Aug 4, 2026 · NCT06195306Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Ap rekriteFaz 2
Laj 18 a 55 · Fanm · Mizajou Jul 27, 2026 · NCT06184750Identifying and Caring for Individuals With Inherited Cancer Syndrome
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT04494945Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
Ap rekriteFaz 2
Laj 35 ak plis · Fanm · Mizajou Jul 7, 2026 · NCT05941520Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT05178498Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer
Ap rekriteFaz 2
Laj 40 ak plis · Fanm · Mizajou Jun 11, 2026 · NCT03936478Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou May 4, 2026 · NCT04169542The PREDICT Registry:
Ap rekriteEtid obsèvasyon
Laj 30 a 85 · Fanm · Mizajou Apr 17, 2026 · NCT03448926Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Apr 16, 2026 · NCT02918474EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou Mar 17, 2026 · NCT07478016Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Mar 12, 2026 · NCT03909282A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
Ap rekriteFaz 1
Laj 18 ak plis · Fanm · Mizajou Mar 5, 2026 · NCT04144023A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Feb 17, 2026 · NCT06350500Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Jan 23, 2026 · NCT049594745 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Fanm · Mizajou Dec 9, 2025 · NCT06961955ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy
Ap rekriteFaz 2
Laj 45 a 79 · Fanm · Mizajou Nov 21, 2025 · NCT06185205A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Sep 18, 2025 · NCT07095114Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.